
Publication
Legalseas
Our shipping law insights provide legal and market commentary, addressing the key questions and topics of interest to our clients operating in the shipping industry, helping them to effectively manage risk.
Publication | November 2020
COVID-19 has put a significant focus on the pharmaceutical industry in the development of treatments and a vaccine. Because the pharmaceutical business is a global industry, legal frameworks vary from region to region, especially in the area of intellectual property. The Pharmaceutical Intellectual Property and Competition Law Review examines the complexities of the industry in multiple jurisdictions providing a useful tool for managing global risks.
Norton Rose Fulbright Canada contributed to this publication, providing an overview of the intellectual property laws in Canada and how they interact with Canada’s competition law.
Publication
Our shipping law insights provide legal and market commentary, addressing the key questions and topics of interest to our clients operating in the shipping industry, helping them to effectively manage risk.
Publication
Our 23rd report spotlights landmark legislative reforms such as the UK’s new Arbitration Act 2025 and South Africa’s rise as a regional arbitration hub. We examine procedural innovations, enforcement challenges, and the evolving role of tribunals in promoting settlement.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025